Finland· FI-REL-REL8127

Lasten Multipekt

A other drugs for obstructive airway diseases, inhalants product, registered in Finland by Schering Oy.

ATC R03BX

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedLasten MultipektATCR03BXREGISTER NO.FI-REL-REL8127PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Manufacturer
Schering Oy
Country
Finland (FI)
ATC code
R03BX
ATC class
Other drugs for obstructive airway diseases, inhalants
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/72ec34d5-27a2-48bd-9624-0569d3840e85
GET /v1/drugs/72ec34d5-27a2-48bd-9624-0569d3840e85?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "mikstuura",
  "route": null,
  "ddd_unit": null,
  "strength": null,
  "atc_label": "Muut ahtauttavien hengitystiesairauksien lääkkeet, inhalaatiot",
  "ma_number": "1441",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL8127",
  "authorised_at": "1965-05-12"
}

See everything about Lasten.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.